Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Scientific Reports|December 14, 2020
Cost-effectiveness of newer technologies for the diagnosis of Mycobacterium tuberculosis infection in Brazilian people living with HIVRicardo E Steffen, Marcia Pinto, Afranio Kritski, et al.
Future Microbiology|June 5, 2010
TMC207: the first compound of a new class of potent anti-tuberculosis drugsAlberto Matteelli, Anna Cc Carvalho, Kelly E Dooley, et al.
BMC Proceedings|March 11, 2017
Catastrophic care-seeking costs as an indicator for lung healthS B Squire, Rachael Thomson, Ireen Namakhoma, et al.
Journal of Biotechnology|August 4, 2011
Recombinant antigen production for assays of intradermoreaction for diagnosis and surveillance of tuberculosisMarcelo Malaghini, Vanete Thomaz-Soccol, Christian Macagnan Probst, et al.
Revista Da Sociedade Brasileira De Medicina Tropical|March 8, 2018
Tuberculosis: renewed challenge in BrazilAfranio Kritski, Kleydson Bonfim Andrade, Rafael Mello Galliez, et al.
Pulmonology|February 5, 2020
Evaluation of pulmonary tuberculosis diagnostic tests in children and adolescents at a pediatric reference centerAndrea M O Rossoni, Kathryn L Lovero, Tonny T Tahan, et al.
The Journal of Infectious Diseases|November 15, 2019
Lack of Weight Gain During the First 2 Months of Treatment and Human Immunodeficiency Virus Independently Predict Unsuccessful Treatment Outcomes in TuberculosisLauren S Peetluk, Peter F Rebeiro, Marcelo Cordeiro-Santos, et al.
Health Promotion Practice|July 21, 2023
Barriers and Facilitators to Integrating Depression Treatment Within a TB Program and Primary Care in BrazilAnnika Claire Sweetland, Claudio Gruber Mann, Maria Jose Fernandes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 2, 2021
A Clinical Prediction Model for Unsuccessful Pulmonary Tuberculosis Treatment OutcomesLauren S Peetluk, Peter F Rebeiro, Felipe M Ridolfi, et al.
Scientific Reports|February 6, 2019
Tuberculosis-associated anemia is linked to a distinct inflammatory profile that persists after initiation of antitubercular therapyLeonardo Gil-Santana, Luís A B Cruz, María B Arriaga, et al.
Pageof 2